Stock 4160 GENETICS GENERATION ADVANCEMENT CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Genetics Generation Advancement Corp.

Equities

4160

TW0004160007

Biotechnology & Medical Research

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-05-05 pm EDT 		5-day change 1st Jan Change
57.1 TWD +7.33% Intraday chart for Genetics Generation Advancement Corp. +3.44% +46.79%
Mar. 25 Genetics Generation Advancement Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Genetics Generation Advancement Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 669.2 685 598.9 601.3 664.4 988.3
Enterprise Value (EV) 1 450.9 454.1 390.4 404.8 409.3 722.5
P/E ratio 40 x 37.7 x -38 x 77.5 x 26.1 x 34.7 x
Yield 2.27% 2.4% - 1.17% 1.74% 1.31%
Capitalization / Revenue 1.75 x 1.6 x 1.35 x 1.16 x 1.21 x 1.67 x
EV / Revenue 1.18 x 1.06 x 0.88 x 0.78 x 0.75 x 1.22 x
EV / EBITDA 27.4 x 28.6 x -23.9 x 226 x 15.3 x 29.1 x
EV / FCF 46.5 x -91.7 x -1,181 x -20.9 x 11.5 x 21.9 x
FCF Yield 2.15% -1.09% -0.08% -4.79% 8.69% 4.57%
Price to Book 2.07 x 1.99 x 1.92 x 1.89 x 1.91 x 2.3 x
Nbr of stocks (in thousands) 25,405 25,405 25,405 25,405 25,405 25,405
Reference price 2 26.34 26.96 23.57 23.67 26.15 38.90
Announcement Date 4/1/19 3/31/20 3/31/21 3/30/22 3/30/23 3/25/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 381.7 429.4 443.1 519.5 547.8 592.5
EBITDA 1 16.48 15.89 -16.36 1.792 26.7 24.81
EBIT 1 11.56 11.28 -21.58 -4.529 20.15 18.58
Operating Margin 3.03% 2.63% -4.87% -0.87% 3.68% 3.14%
Earnings before Tax (EBT) 1 18.09 20.89 -18.28 10.2 33.19 34.74
Net income 1 16.88 18.3 -15.7 7.839 25.73 28.56
Net margin 4.42% 4.26% -3.54% 1.51% 4.7% 4.82%
EPS 2 0.6586 0.7158 -0.6204 0.3054 1.002 1.120
Free Cash Flow 1 9.702 -4.949 -0.3306 -19.39 35.56 32.99
FCF margin 2.54% -1.15% -0.07% -3.73% 6.49% 5.57%
FCF Conversion (EBITDA) 58.88% - - - 133.19% 132.99%
FCF Conversion (Net income) 57.46% - - - 138.19% 115.5%
Dividend per Share 2 0.5982 0.6484 - 0.2777 0.4558 0.5100
Announcement Date 4/1/19 3/31/20 3/31/21 3/30/22 3/30/23 3/25/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 218 231 208 197 255 266
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 9.7 -4.95 -0.33 -19.4 35.6 33
ROE (net income / shareholders' equity) 5.33% 5.53% -4.7% 2.54% 7.79% 7.4%
ROA (Net income/ Total Assets) 1.85% 1.68% -3.17% -0.68% 2.86% 2.21%
Assets 1 912.1 1,091 494.7 -1,155 899.3 1,293
Book Value Per Share 2 12.70 13.60 12.30 12.60 13.70 16.90
Cash Flow per Share 2 2.780 1.750 2.700 3.360 2.260 5.060
Capex 1 2.7 1.89 8.87 7.95 7.05 3.73
Capex / Sales 0.71% 0.44% 2% 1.53% 1.29% 0.63%
Announcement Date 4/1/19 3/31/20 3/31/21 3/30/22 3/30/23 3/25/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Bio Diagnostics & Testing

1st Jan change Capi.
GENETICS GENERATION ADVANCEMENT CORP. Stock Genetics Generation Advancement Corp.
+46.79% 41.86M
EXACT SCIENCES CORPORATION Stock Exact Sciences Corporation
-14.37% 11.41B
IOVANCE BIOTHERAPEUTICS, INC. Stock Iovance Biotherapeutics, Inc.
+70.73% 3.81B
GUARDANT HEALTH, INC. Stock Guardant Health, Inc.
-29.39% 2.3B
BGI GENOMICS CO., LTD. Stock BGI Genomics Co., Ltd.
-12.90% 2.16B
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock Maravai LifeSciences Holdings, Inc.
+37.56% 1.19B
SEEGENE, INC. Stock Seegene, Inc.
-2.40% 760M
CAREDX, INC Stock CareDx, Inc
-15.17% 506M
ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Adaptive Biotechnologies Corporation
-34.29% 444M
CURIOX BIOSYSTEMS CO., LTD Stock Curiox Biosystems Co., Ltd
+13.72% 339M
Bio Diagnostics & Testing
  1. Stock Market
  2. Equities
  3. 4160 Stock
  4. Financials Genetics Generation Advancement Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW